Triple-Negative Breast Cancer: Progress of Immune-Based Combinations and Novel Targeted Therapies

Download the slides from an expert-led Webinar to review the latest strategies for integrating immune checkpoint inhibitors and targeted therapies into the continuum of TNBC from early-stage disesase through metastatic setting.

Share

Program Content

No activities added yet

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Genentech, a member of the Roche Group